Alcon’s ALC AcrySof IQ Vivity and Clareon Vivity extended depth of focus (EDOF) intraocular lenses (IOLs) have recently surpassed more than one million implants worldwide.The company’s ...
Q4 2024 Management View CEO David Endicott highlighted 2024 as a strong year for Alcon, with annual sales reaching $9.8 billion, a 6% increase, and core diluted EPS growing by 16% to $3.05. Free cash ...
The first-line laser treatment for glaucoma and ocular hypertension will be unveiled at the 2025 American Glaucoma Society ...
Traditional SLT involves using a laser to manipulate the eye's trabecular meshwork, located around the base of the cornea, ...
Alcon (ALC) announced he full U.S. commercial availability of Voyager DSLT, the first and only Direct Selective Laser Trabeculoplasty device .